Physicians often find it hard to tell if a patient suffering from dementia or depression is capable of making sound judgements. This is shown by a study conducted within the scope of the National Research Programme “End of Life” (NRP 67). The Central Ethics Committee of the Swiss Academy of Medical Sciences now aims to elaborate new assessment principles.
The question whether a patient is capable of making sound judgements is of central importance for all medical treatments. Only patients who are able to understand, retain and weigh the information they receive from the physician can give their valid consent to a treatment. If the patient’s decision-making capacity is impaired, according to current legislation the physician needs to consider a living will or consult a patient-appointed proxy.
“Brain injuries or illnesses such as dementia or severe depression can cause an incapacity to make decisions,“ says Manuel Trachsel, senior assistant at the Institute for Biomedical Ethics of the University of Zurich. This is particularly so when people with a terminal illness reach the end of life. Some crucial and complex decisions are needed at this stage: Should life-prolonging measures be discontinued? Is the patient perhaps contemplating an assisted suicide?
Anything but trivial
“Assessing someone’s decision-making capacity is anything but trivial,“ says Trachsel. The result of the assessment may not be the same for all situations. For instance, someone may be regarded as capable of adequate decision-making when it comes to everyday matters such as clothes or food, but as incapable of just this in relation to a difficult medical decision. In addition, the cognitive capacities of patients suffering from Alzheimer’s or Parkinson’s disease can fluctuate considerably from day to day. In a specialist journal, Trachsel and his colleagues Helena Hermann and Nikola Biller-Andorno recently discussed how physicians might nonetheless be able to assess decision-making capacity in such difficult circumstances (*).
But what do physicians understand by “decision-making capacity” in the first place? In the context of the National Research Programme “End of Life“ (NRP 67), Trachsel interviewed around 760 physicians from all over Switzerland. The results, which have now been published (**), suggest that the vast majority of physicians feel they are responsible for assessing the patient’s decision-making capacity. However, even among those with a very strong sense of responsibility, only about one third believe they are competent enough.
Rules of thumb vs guidelines
Physicians show a lack of consensus when it comes to defining decision-making capacity, identifying the key assessment criteria and describing the way in which they assess someone’s ability to make decisions. “Most physicians apply their own rules of thumb to determine whether a patient is capable of making decisions or not,” says Trachsel. Few of them are aware that various guidelines for assessing someone’s decision-making capacity are already in place.
Nevertheless, among the interviewed physicians an overwhelming majority expressed a desire to have access to such assessment tools. A large majority was in favour of clear guidelines and showed an interest in taking courses on the subject. These innovations will soon be a reality: based on the results of the survey, the Central Ethics Committee of the Swiss Academy of Medical Sciences (SAMS) has decided to engage with the topic and elaborate principles for assessing medical decision-making capacity as of next year.
(*) Manuel Trachsel, Helena Hermann, Nikola Biller-Andorno (2014). Cognitive Fluctuations as a Challenge for the Assessment of Decision-Making Capacity in Patients with Dementia. American Journal of Alzheimer’s Disease online. doi: 10.1177/1533317514539377
(available to journalists as a PDF file from firstname.lastname@example.org)
(**) Helena Hermann, Manuel Trachsel, Christine Mitchell, Nikola Biller-Andorno (2014). Medical decision-making capacity: knowledge, attitudes, and assessment practices of physicians in Switzerland. Swiss Medical Weekly online. doi: 10.4414/smw.2014.14039
Dr Manuel Trachsel
Institute for Biomedical Ethics and History of Medicine
University of Zurich
Tel.: +41 78 685 44 54
Media - Abteilung Kommunikation | idw - Informationsdienst Wissenschaft
Smart Data Transformation – Surfing the Big Wave
02.12.2016 | Fraunhofer-Institut für Angewandte Informationstechnik FIT
Climate change could outpace EPA Lake Champlain protections
18.11.2016 | University of Vermont
In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.
Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...
Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...
A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.
Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...
In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.
“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...
The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.
The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...
16.11.2016 | Event News
01.11.2016 | Event News
14.10.2016 | Event News
08.12.2016 | Life Sciences
08.12.2016 | Physics and Astronomy
08.12.2016 | Materials Sciences